Active	Status	Sponsor type	Region	Phase	Filter
9 Active 0 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sayegh, Alain
NAV3-33, NCT05246280: Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA	Terminated	3	196	US	TC99m-tilmanocept, tilmanocept, Lymphoseek	Navidea Biopharmaceuticals	Rheumatoid Arthritis	07/24	07/24
C4951003, NCT04743141: Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine	Recruiting	3	200	Europe, US	Rimegepant (PF-07899801)	Pfizer	Acute Treatment of Migraine	06/27	06/27
NCT04649242 / 2020-003517-35: Randomized Study in Children and Adolescents With Migraine: Acute Treatment	Recruiting	3	2100	Europe, Canada, Japan, US, RoW	Rimegepant/BHV3000, Matching placebo	Pfizer	Pediatric Migraine	01/29	01/29
NCT05156398 / 2021-005246-15: Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects	Recruiting	3	640	Europe, Canada, Japan, US	Rimegepant, BHV3000, Placebo, Matching Placebo	Pfizer, Biohaven Pharmaceuticals Holding Company Limited	Migraine	04/27	04/27
NCT05686044: A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD	Completed	2/3	320	US	Buntanetap/Posiphen, Posiphen Tartrate, Placebo	Annovis Bio Inc.	Alzheimer Disease	02/24	02/24
SANRECO, NCT05499013: Study to Assess SLN124 in Patients With Polycythemia Vera	Recruiting	1/2	65	Europe, US, RoW	SLN124, Placebo	Silence Therapeutics plc	Polycythemia Vera	12/24	06/25
Belinga, Steve Felix
NCT05686044: A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD	Completed	2/3	320	US	Buntanetap/Posiphen, Posiphen Tartrate, Placebo	Annovis Bio Inc.	Alzheimer Disease	02/24	02/24
Pettit, Jennifer
NCT05686044: A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD	Completed	2/3	320	US	Buntanetap/Posiphen, Posiphen Tartrate, Placebo	Annovis Bio Inc.	Alzheimer Disease	02/24	02/24
Khoury, Sally
NCT05686044: A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD	Completed	2/3	320	US	Buntanetap/Posiphen, Posiphen Tartrate, Placebo	Annovis Bio Inc.	Alzheimer Disease	02/24	02/24